| JOURNAL OF CONTROLLED RELEASE | 卷:334 |
| Mechanobiology-informed regenerative medicine: Dose-controlled release of placental growth factor from a functionalized collagen-based scaffold promotes angiogenesis and accelerates bone defect healing | |
| Article | |
| Sheehy, Eamon J.1,2,3,4  Miller, Gregory J.1,2  Amado, Isabel1,2  Raftery, Rosanne M.1,2  Chen, Gang5  Cortright, Kai1,2  Vazquez, Arlyng Gonzalez1,2  O'Brien, Fergal J.1,2,3,4  | |
| [1] Royal Coll Surgeons Ireland, Dept Anat & Regenerat Med, Tissue Engn Res Grp TERG, Dublin, Ireland | |
| [2] Trinity Coll Dublin, Trinity Biomed Sci Inst, Trinity Ctr Biomed Engn, Dublin, Ireland | |
| [3] Royal Coll Surgeons Ireland, Adv Mat & Bioengn Res Ctr AMBER, Dublin, Ireland | |
| [4] Trinity Coll Dublin, Dublin, Ireland | |
| [5] Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Ctr Study Neurol Disorders, Microsurg Res & Training Facil MRTF, Dublin, Ireland | |
| 关键词: Drug delivery; Vascularization; Osteogenesis; PGF; Alginate; Microparticles; Hydroxyapatite; | |
| DOI : 10.1016/j.jconrel.2021.03.031 | |
| 来源: Elsevier | |
PDF
|
|
【 摘 要 】
Leveraging the differential response of genes to mechanical loading may allow for the identification of novel therapeutics and we have recently established placental growth factor (PGF) as a mechanically augmented gene which promotes angiogenesis at higher doses and osteogenesis at lower doses. Herein, we sought to execute a mechanobiology-informed approach to regenerative medicine by designing a functionalized scaffold for the dose-controlled delivery of PGF which we hypothesized would be capable of promoting regeneration of critically-sized bone defects. Alginate microparticles and collagen/hydroxyapatite scaffolds were shown to be effective PGF-delivery platforms, as demonstrated by their capacity to promote angiogenesis in vitro. A PGF release profile consisting of an initial burst release to promote angiogenesis followed by a lower sustained release to promote osteogenesis was achieved by incorporating PGF-loaded microparticles into a collagen/hydroxyapatite scaffold already containing directly incorporated PGF. Although this PGF-functionalized scaffold demonstrated only a modest increase in osteogenic capacity in vitro, robust bone regeneration was observed after implantation into rat calvarial defects, indicating that the dose-dependent effect of PGF can be harnessed as an alternative to multidrug systems for the delivery of both pro-angiogenic and pro-osteogenic cues. This mechanobiology-informed approach provides a framework for strategies aimed at identifying and evaluating novel scaffold-based systems for regenerative applications.
【 授权许可】
Free
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| 10_1016_j_jconrel_2021_03_031.pdf | 2473KB |
PDF